Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
470.90
Nov 11 • 3:59 PM ET Dollar change-4.62 Percentage change(-0.97%)
Aftermarket Close
470.90
Aftermarket • 7:32 PM ET Dollar change0.00 Percentage change(0.00%)
Nov 10, 8:37 AMWaters receives FDA 510(k) clearance for BD OneFlow LST and BD OneFlow B-CLPD T1 diagnostic tests
Index
S&P 500, RUI
Market Cap
46.27B
Enterprise Value
51.17B
Income
98.21M
Sales
5.61B
Book/sh
155.60
Cash/sh
6.04
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
7900
IPO
Nov 17, 1995
P/E
202.52
Forward P/E
28.50
PEG
2.32
P/S
8.24
P/B
3.03
P/C
78.02
P/FCF
173.11
EV/EBITDA
36.66
EV/Sales
9.12
Quick Ratio
1.28
Current Ratio
1.89
Debt/Eq
0.36
LT Debt/Eq
0.31
Option/Short
Yes / Yes
EPS (ttm)
2.33
EPS next Y
16.53
EPS next Q
4.66
EPS this Y
11.77%
EPS next Y
12.60%
EPS next 5Y
12.29%
EPS past 3/5Y
-2.83% 5.19%
Sales past 3/5Y
2.12% 6.00%
EPS Y/Y TTM
-78.49%
Sales Y/Y TTM
80.68%
EPS Q/Q
-67.24%
Sales Q/Q
120.91%
Insider Own
0.14%
Insider Trans
-2.57%
Inst Own
104.58%
Inst Trans
1.06%
ROA
0.68%
ROE
1.11%
ROIC
0.49%
Gross Margin
38.05%
Oper. Margin
9.54%
Profit Margin
1.75%
SMA20
2.59%
SMA50
7.44%
SMA200
26.45%
Trades
Shs Outstand
98.27M
Shs Float
98.11M
52W High
482.28 -2.36%
52W Low
282.77 66.53%
Volatility
3.56% 3.63%
ATR (14)
15.65
RSI (14)
58.28
Beta
1.14
Rel Volume
0.79
Avg Volume
828.99K
Volume
652,123
Perf Week
0.71%
Perf Month
9.72%
Perf Quarter
13.88%
Perf Half Y
40.60%
Perf YTD
23.98%
Perf Year
21.95%
Perf 3Y
84.00%
Perf 5Y
34.35%
Perf 10Y
231.41%
Prev Close
475.52
Price
470.90
Change %
-0.97%
Consensus
Buy
Avg. Price Target
$509.76
Implied Upside
+8.3%
Analysts16incl. previous ratings
Rating Distribution15 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 09, 2026Resumed
UBS logoUUBS
Buy$490+4.1%
Aug 27, 2026Upgrade
PPiper Sandler
Neutral → Overweight$480+1.9%
Aug 05, 2026Upgrade
TD logoTTD Cowen
Hold → Buy$475+0.9%
Jul 09, 2026Initiated
RY logoRRBC Capital Mkts
Outperform$435-7.6%
Jun 26, 2026Resumed
BBernstein
Outperform$435-7.6%
Jun 11, 2026Initiated
PPiper Sandler
Neutral$400-15.1%
Jun 02, 2026Resumed
WWolfe Research
Outperform$425-9.7%
Apr 06, 2026Upgrade
EVR logoEEvercore ISI
In-line → Outperform$350-25.7%
Feb 10, 2026Resumed
EVR logoEEvercore ISI
In-line$360-23.6%
Feb 10, 2026Resumed
C logoCCitigroup
Buy$425-9.7%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KUEBLER CHRISTOPHER ADirectorAug 06 '26Option Exercise136.433,626494,69521,434Aug 07 05:20 PM
KUEBLER CHRISTOPHER ADirectorAug 06 '26Sale397.943,6261,442,93017,808Aug 07 05:20 PM
KUEBLER CHRISTOPHER ADirectorAug 06 '26Proposed Sale397.943,6261,442,930Aug 06 10:40 AM
Jiang WeiDirectorMar 16 '26Buy289.46500144,7303,441Mar 18 04:37 PM
FEARON RICHARD HDirectorMar 06 '26Buy306.341,000306,3403,302Mar 10 04:21 PM
Waters Corp. engages in the provision of workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis. It operates through the Waters and TA (TA Instruments) segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and services. The TA segment products and services include thermal analysis, rheometry and calorimetry instrument systems, and service sales. The company was founded by James Logan Waters in 1958 and is headquartered in Milford, MA.
PresidentDr. Udit Batra Ph.D.
Senior VP & CFOMr. Amol Chaubal
Senior Vice President of Waters Advanced Diagnostics DivisionMs. Jianqing Y. Bennett
SVP of Global OperationsMr. Mark Gladwell
Senior VP & Chief Information OfficerMr. Brook M. Colangelo